Mitsubishi UFJ Asset Management
IRWD icon

Mitsubishi UFJ Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,043
Closed -$1.53K – 1632
2025
Q1 		$1.53K Hold
1,043
– – ﹤0.01% 1586
2024
Q4 		$4.7K Hold
1,043
– – ﹤0.01% 1454
2024
Q3 		$4.3K Hold
1,043
– – ﹤0.01% 1459
2024
Q2 		$6.8K Hold
1,043
– – ﹤0.01% 1298
2024
Q1 		$9.09K Hold
1,043
– – ﹤0.01% 1176
2023
Q4 		$12.8K Hold
1,043
– – ﹤0.01% 1112
2023
Q3 		$10K Buy
+1,043
New +$10.2K ﹤0.01% 1111

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Mitsubishi UFJ Asset Management's IRWD Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 1,043 shares — an estimated $1.53K sold.

Mitsubishi UFJ Asset Management first reported a position in IRWD in Q3 2023 and held it in 7 quarters. The position peaked at $12.8K in Q4 2023. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Mitsubishi UFJ Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 1,043 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $1.53K.
  • Mitsubishi UFJ Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 7 quarters.
  • Mitsubishi UFJ Asset Management's Ironwood Pharmaceuticals position peaked at $12.8K in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.